Key Highlights
- Dr. Susan Billings joins Resilience as Chief Commercial Officer.
- Brings 15+ years of leadership in commercial strategy and biotech partnerships.
- Previously served as CCO of Vivodyne and VP at Curia, leading global business development.
- Focuses on revenue growth, market expansion, and high-performing commercial teams.
Source: Business Wire
Notable Quotes
- “We are thrilled to welcome Susan to our team at such a critical time in our company’s evolution.” — Rahul Singhvi, Sc.D., CEO at Resilience
- “I am honored to join Resilience at this transformative stage in its growth journey.” — Dr. Susan Billings, Chief Commercial Officer at Resilience
SoHC's Take
The appointment of Dr. Susan Billings as Chief Commercial Officer signals Resilience’s commitment to strengthening its commercial strategy and global market reach. Her deep experience in scaling business development in biopharma, paired with her innovative leadership, will position Resilience for continued growth. With her extensive background in both start-ups and large organizations, Dr. Billings is well-equipped to lead Resilience through its next phase of commercial success and ensure that the company remains at the forefront of biomanufacturing innovation.
